Related Experiment Videos
Human beta-galactosidase gene mutations in morquio B disease
A Oshima1, K Yoshida, M Shimmoto
1Department of Clinical Genetics, Tokyo Metropolitan Institute of Medicine Science, Japan.
American Journal of Human Genetics
|November 1, 1991
Summary
Researchers identified three beta-galactosidase gene mutations in patients with Morquio B disease. Mutation F, a common two-base substitution, was uniquely associated with specific clinical manifestations, showing some enzyme activity.
Area of Science:
- Genetics
- Biochemistry
- Molecular Biology
Background:
- Morquio B disease is a rare genetic disorder.
- It is caused by mutations in the beta-galactosidase gene.
- Understanding genotype-phenotype correlations is crucial for this disease.
Purpose of the Study:
- To identify and characterize beta-galactosidase gene mutations in patients with Morquio B disease.
- To investigate the functional consequences of identified mutations on enzyme activity.
- To correlate specific mutations with clinical manifestations.
Main Methods:
- Genetic analysis to identify mutations (273Trp----Leu, 482Arg----His, 509Trp----Cys).
- Restriction-site analysis (StuI, Nsp(7524)I, RsaI) for mutation confirmation.
- Enzyme activity assays in human fibroblasts.
Main Results:
- Three distinct beta-galactosidase gene mutations were identified in three patients from two families.
- Mutation F (273Trp----Leu) showed 8% of normal enzyme activity in fibroblasts.
- Mutations G (482Arg----His) and H (509Trp----Cys) resulted in no detectable enzyme activity.
- Mutation F is a common two-base substitution.
Conclusions:
- Specific beta-galactosidase gene mutations are associated with Morquio B disease.
- Mutation F is uniquely linked to distinct clinical features due to residual enzyme activity.
- Genotype-phenotype correlation is established for these mutations in Morquio B disease.